Brian Kieser was named Chief Executive Officer of Nexgel, Inc. As of November 6, 2026, Nexgel, Inc. has reported 4 leadership change filings to the SEC under Item 5.02 of Form 8-K, from April 30, 2026 to August 21, 2026, naming 2 appointments and 1 departure (Form 8-K, August 21, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like Nexgel, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · In / out: In · Person: Brian Kieser · Role: Chief Executive Officer · 8-K, 2026-08-21
- · In / out: Out · Person: Scott Henry · 8-K, 2026-07-02
- · In / out: Reported · Person: not named in the filing · 8-K, 2026-05-12
- · In / out: In · Person: Ian Blackman · Role: Chief Financial Officer · Effective: 2026-04-27 · 8-K, 2026-04-30
Nexgel, Inc. reported changes in 4 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-04-30 to 2026-08-21. They name 3 people, with 2 appointments and 1 departure. Every row below is cited to the filing it comes from, and this page adds each new change as Nexgel, Inc. files it.
Also on the record for Nexgel, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| April 29, 2026 | Stake report, Schedule 13G/A, by Asymmetry Point LP | 8.8% of the class | 5%+ stakes | Source |
| March 12, 2026 | Stake report, Schedule 13G, by Asymmetry Point LP | 7.49% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs Nexgel, Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on Nexgel, Inc. and the records around it.
Nexgel, Inc. elsewhere on the record
Companies that share a holder
- Asymmetry Point LP also filed stake reports on 1 other company: QVC Group, Inc. (Apr 2026)
Watch Nexgel, Inc.
Get an email when Nexgel, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Nexgel, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Nexgel, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Nexgel, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
6 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-08-21 | In | Chief Executive Officer | 8-K, 2026-08-21 | ||
| 2026-07-02 | Out | 8-K, 2026-07-02 | |||
| 2026-05-12 | Reported | not named in the filing | 8-K, 2026-05-12 | ||
| 2026-04-30 | In | Chief Financial Officer | 2026-04-27 | 8-K, 2026-04-30 |
Who leads Nexgel, Inc., as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Chief Executive Officer: Brian Kieser, appointed (filed 2026-08-21).
- Chief Financial Officer: Ian Blackman, appointed, effective 2026-04-27 (filed 2026-04-30).
New leaders reset buying decisions — get the Full Report on Nexgel, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Chief Executive Officer at Nexgel, Inc., with the record behind each one.
Find candidates like Chief Executive Officer at Nexgel, Inc.Every change, in the filing's words
Appointed: Brian Kieser, Chief Executive Officer
Effective as of the Separation Date, the Board appointed Brian Kieser to serve as Interim Chief Executive Officer of the Company.
- Effective August 21, 2026 (the "Separation Date"), NexGel, Inc. (the "Company") terminated Adam R. Levy's employment as Chief Executive Officer without Cause (as defined in Mr. Levy's Executive Employment Agreement, dated July 23, 2026), and Mr. Levy resigned from the Company's Board of Directors (the "Board") and from all other officer, director, committee and fiduciary positions held by him with the Company and its subsidiaries.
- In connection with Mr. Levy's departure, the Company and Mr. Levy are negotiating a Separation Agreement and Release, the material terms of which have not yet been finalized.
- Mr. Kieser has served as a member of the Board since May 6, 2026.
- Mr. Kieser, age 59, is the Founder and Chief Executive Officer of Fountainhead Lifesciences (f/k/a Fountainhead Biomedical Holdings) ("Fountainhead"), a San Antonio-based venture platform designed to create, scale, and commercialize next-generation medical technologies.
- Through Fountainhead, Mr. Kieser has assembled a vertically integrated ecosystem of companies focused on orthopedic medical devices, regenerative biologics, and advanced biomedical manufacturing, including Nvision Biomedical Technologies, Sequence LifeScience, Inc. ("Sequence"), and Lockhill Advanced Manufacturing Technologies.
- Mr. Kieser also serves as Chief Executive Officer of Sequence.
Departing: Scott Henry
On June 29, 2026, Scott Henry notified NexGel, Inc. (the " Company ") of his intent to resign as a member of the Company's Board of Directors (the " Board ") to lighten his schedule and give attention to other business ventures and personal matters.
- Mr. Henry's resignation is effective as of July 1, 2026.
- Mr. Henry was the Chairperson of the Board's Audit Committee and a member of the Board's Compensation Committee and Nominating and Corporate Governance Committee.
- Mr. Henry's resignation is not as a result of any disagreement with the Company or any of its subsidiaries on any matters related to their operation, policies or practices.
Reported
On May 6, 2026, Brian J. Kieser and Kevin M. Harris (collectively, the " Board Appointees ") were appointed to the board of directors (the " Board ") of NexGel, Inc. (the " Company ") to serve for a term expiring at the Company's next annual meeting of stockholders or until their successors are duly elected and qualified.
- The Board Appointees did not receive any compensation in connection with their respective appointments to the Board.
- Each of Mr. Kieser and Mr. Harris will be entitled to receive compensation for service on the Board consistent with the compensation paid by the Company to its other non-employee directors, as may be determined from time to time by the Board.
- Mr. Kieser also has a direct material interest in the convertible promissory note and warrant issued to him in his individual capacity on May 11, 2026.
- Mr. Harris serves as the Chief Operating Officer of Sequence but does not have any equity ownership interest in Sequence or its parent.
Appointed: Ian Blackman, Chief Financial Officer, effective 2026-04-27
On April 27, 2026, the Board of Directors of the Company (the " Board ") appointed Ian Blackman, age 58, as Chief Financial Officer of NexGel, Inc. (the " Company "), effective April 27, 2026.
- Mr. Blackman succeeds Mr. Drapczuk as the Company's principal financial officer and principal accounting officer.
- Mr. Blackman, 58, is a Certified Public Accountant with over 30 years of global financial leadership experience across private equity-backed and publicly traded organizations.
- From February 2018 until September 2025, Mr. Blackman served as Chief Financial Officer of McIntosh Group Inc. (and its successor, Bose Luxury), a private equity-backed luxury consumer electronics company, where he was a member of the executive team that drove organic revenue growth and was deeply involved in two due diligence and sale processes resulting in transactions to a private equity firm and subsequently to a strategic acquirer.
- From April 2017 to January 2018, Mr. Blackman served as Chief Financial Officer, North America, for Diptyque and Byredo, two private equity-backed luxury lifestyle brands, where he was responsible for all finance, treasury, tax and human resources functions.
- From 1995 to September 2011, Mr. Blackman served in roles of increasing responsibility at Universal Music Group.
- Mr. Blackman began his career at Goldstein Golub Kessler and Company, where he served as an Audit Manager from 1989 to 1995.
- Mr. Blackman holds a Bachelor of Science (Honours) in Economics from the London School of Economics.
Tools for this story
Each opens in a new tab, filled in for Nexgel, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.